Teprotumumab for the treatment of thyroid eye disease: The Holy grail, really?

被引：1
|
作者：
Martel, A. [1 ]
机构：
[1] Cote Azur Univ, Univ Hosp Nice, Ophthalmol Dept, 30, voie Romaine, F-06000 Nice, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2023年 / 46卷 / 06期
关键词：
GRAVES ORBITOPATHY; RITUXIMAB;
D O I：
10.1016/j.jfo.2023.01.003
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：567 / 570
页数：4
相关论文
共 50 条
  • [31] Thyroid Eye Disease: Towards an Evidence Base for Treatment in the 21st Century
    Erin F. Gillespie
    Terry J. Smith
    Raymond S. Douglas
    Current Neurology and Neuroscience Reports, 2012, 12 : 318 - 324
  • [32] Thyroid Eye Disease: Towards an Evidence Base for Treatment in the 21st Century
    Gillespie, Erin F.
    Smith, Terry J.
    Douglas, Raymond S.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (03) : 318 - 324
  • [33] Orbital corticosteroid injections for the treatment of active thyroid eye disease
    Eid, Kevin T.
    Kally, Peter M.
    Kahana, Alon
    FRONTIERS IN OPHTHALMOLOGY, 2024, 3
  • [34] Predictive factors for treatment response in active thyroid eye disease
    Alkmim, Nina R.
    Rajao, Kamilla M. A. B.
    Figueiredo, Ana R. P.
    Braga, Walter R. C.
    Silveira, Leticia F. G.
    ANNALES D ENDOCRINOLOGIE, 2024, 85 (06) : 582 - 588
  • [35] A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients
    Hiromatsu, Yuji
    Ishikawa, Eri
    Kozaki, Ai
    Takahashi, Yasuhiro
    Tanabe, Mika
    Hayashi, Ken
    Imagawa, Yukihiro
    Kaneda, Kazutoyo
    Mimura, Masashi
    Dai, Xiaoxian
    Hayashida, Tomoko
    Akamizu, Takashi
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2025, 55
  • [36] Recurrent Thyroid Eye Disease
    Patel, Payal
    Khandji, Joyce
    Kazim, Michael
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2015, 31 (06): : 445 - 448
  • [37] Thyroid eye disease: a review
    Weiler, Danielle L.
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2017, 100 (01) : 20 - 25
  • [38] Immunotherapies for thyroid eye disease
    Kahaly, George J.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2019, 26 (05) : 250 - 255
  • [39] Methotrexate as an Adjuvant in Severe Thyroid Eye Disease: Does It Really Work as a Steroid-Sparing Agent?
    Yong, Kai-Ling
    Chng, Chiaw-Ling
    Sie, Nicole Ming
    Lang, Stephanie
    Yang, Morgan
    Looi, Audrey
    Choo, Chai-Teck
    Shen, Sunny
    Seah, Lay Leng
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2019, 35 (04): : 369 - 373
  • [40] Treatment of corticosteroid-resistant thyroid eye disease with subcutaneous tocilizumab
    Silkiss, Rona Z.
    Paap, Michael K.
    Roelofs, Kelsey A.
    Agi, Jorge
    Weis, Ezekiel
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2021, 56 (01): : 66 - 70
12345